SMARCA4 regulates spatially restricted metabolic plasticity in 3D multicellular tissue
Kateřina ČermákováiD, Eric A. SmithiD, Yuen San ChaniD, Mario Loeza CabreraiD, Courtney ChambersiD, Maria JarvisiD, Lukas Mikolaj SimoniD, Yuan Xu, Abhinav K. JainiD, Nagireddy PutluriiD, Rui CheniD, Robert Taylor RipleyiD, Omid Veiseh AiD, H. Courtney HodgesiD
Abstract
SWI/SNF and related chromatin remodeling complexes act as tissue-specific tumor suppressors and are frequently inactivated in different cancers. Although many regulatory activities of SWI/SNF have been identified using 2D cell culture, the effects of SWI/SNF alterations in more complex 3D tissues have remained poorly understood. Here we employed 3D cell culture conditions that yield transcriptomic states mirroring primary lung adenocarcinoma (LUAD) specimens better than 2D culture. By analyzing spatial patterns of gene expression and DNA accessibility in 3D spheroids using single-cell RNA-seq and ATAC-seq, we find that the SWI/SNF ATPase SMARCA4 (BRG1) induces state-specific changes to DNA accessibility that influence spatially heterogeneous expression patterns and metabolism. In 3D conditions, SMARCA4 promotes accessibility for AP-1 transcription factors, including ATF3, a regulator of metabolism and repressor of NRF2 antioxidant signaling. These changes reduce expression of SLC7A11 in a distinct portion of cells, which sensitizes A549 spheroids to cell death via ferroptosis under oxidizing conditions. Consistent with these results, we find that SMARCA4 alterations are associated with derepression of NRF2 targets in human tumors independently of NRF2/KEAP1 status. Our work reveals new 3D-specific features and unanticipated spatial complexity associated with chromatin remodeling in multicellular tissues.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SMARCA4 supports the oncogenic landscape of KRAS-driven lung tumors
E. Collisson·bioRxiv·Apr 18, 2020
- A Non-Canonical Role of SMAD4 in Regulating 3D Genome Architecture to Inhibit Lung Squamous Cell Carcinoma Development
Qian Tang, Chen Lian, … Jian Liu·Advanced SciencePeer-reviewed·May 26, 2026
- SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A. Kirk, Jin Ng, … Kwon-Sik Park·bioRxiv·May 21, 2025
- Role of Specialized mSWI/SNF Complexes in Prostate Cancer Lineage Plasticity
J. Cyrta, A. Augspach, … M. Rubin·Nature CommunicationsPeer-reviewed·Nov 3, 2020
- SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
Violeta Garcia-Hernandez, Maria Maqueda, … Anna Bigas·bioRxiv·Nov 3, 2026
- Shifted assembly and function of mSWI/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas
Jessica D. St. Laurent, Grace Dydian Xu, … Cigall Kadoch·Nature GeneticsPeer-reviewed·Oct 20, 2025